Ketorolac

Question 1

Ketorolac Trade Name

Answer 1

Toradol

Question 2

Ketorolac Classification

Answer 2

CT Protocols:
Non-steroidal anti-inflammatory
Non-opioid analgesic

Question 3

Ketorolac Mechanism

Answer 3

Capital:
Inhibits the synthesis of prostaglandins to decrease pain and inflammation

New Britain:
Nonselective competitive antagonist of COX causing prostaglandin synthesis inhibition, analgesic, anti-inflammatory and antipyretic properties. Acts peripherally not centrally and therefor does not possess the sedative effects of narcotics.

Question 4

Ketorolac Onset of Action

Answer 4

Capital:
10 minutes

Question 5

Ketorolac Duration of Action

Answer 5

Capital:
2-6 hours

Question 6

Ketorolac Indications

Answer 6

CT Protocols:
Moderate to severe pain

Question 7

Ketorolac Contraindications

Answer 7

CT Protocols:
Allergy, Pregnancy, Renal insufficiency, Peptic ulcer, Potential for bleeding/likely to need surgery, Undifferentiated abdominal pain, Suspected fracture,
Do not combine with another NSAID

Question 8

Ketorolac Side Effects/ Precautions/ Comments

Answer 8

Capital:
GI bleeding, Edema, Bronchospasm, Dizziness, Hypertension, Nausea/vomiting, Hypotension, Sedation

Question 9

Ketorolac Adult Dose

Answer 9

CT Protocols:
15mg IV/IO/IM

Question 10

Ketorolac Pediatric Dose

Answer 10

Capital:
Not recommended

Question 11

Ketorolac Max Dose Adult (Pediatric)

Answer 11

Not noted

Question 12

Ketorolac Routes of Administration

Answer 12

IV/IO/IM

Question 13

Ketorolac How Supplied

Answer 13

15mg/ml and 30mg/ml vials